Mar 22, 2026Do GLP-1 Drugs Protect the Brain? The Evidence So FarDo semaglutide and other GLP-1 drugs lower Parkinson's or Alzheimer's risk? Examine the observational signals, bias tests, and missing trial data.glp-1 agonistssemaglutideparkinson's diseaseRead article →
Mar 21, 2026Do GLP-1 Drugs Lower Seizure Risk? An Early SignalGLP-1 receptor agonists showed fewer seizure events in diabetes trials, but sparse data, stroke effects, and weak endpoints limit conclusions.glp-1ozempicvictozaRead article →